| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |